These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 7964745

  • 1. Autoradiographic distribution and characteristics of high- and low-affinity polyamine-sensitive [3H]ifenprodil sites in the rat brain: possible relationship to NMDAR2B receptors and calmodulin.
    Nicolas C, Carter C.
    J Neurochem; 1994 Dec; 63(6):2248-58. PubMed ID: 7964745
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterisation and autoradiographic distribution of polyamine-sensitive [3H]ifenprodil binding sites in the rat brain.
    Dana C, Benavides J, Schoemaker H, Scatton B.
    Neurosci Lett; 1991 Apr 15; 125(1):45-8. PubMed ID: 1830379
    [Abstract] [Full Text] [Related]

  • 3. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
    Mugnaini M, van Amsterdam FT, Ratti E, Trist DG, Bowery NG.
    Br J Pharmacol; 1996 Nov 15; 119(5):819-28. PubMed ID: 8922727
    [Abstract] [Full Text] [Related]

  • 4. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
    Coughenour LL, Barr BM.
    J Pharmacol Exp Ther; 2001 Jan 15; 296(1):150-9. PubMed ID: 11123375
    [Abstract] [Full Text] [Related]

  • 5. Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex.
    Berger ML, Rebernik P.
    J Pharmacol Exp Ther; 1999 Jun 15; 289(3):1584-91. PubMed ID: 10336556
    [Abstract] [Full Text] [Related]

  • 6. Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds.
    Nankai M, Klarica M, Fage D, Carter C.
    Neurochem Int; 1996 Nov 15; 29(5):529-42. PubMed ID: 8939463
    [Abstract] [Full Text] [Related]

  • 7. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL, Cordon JJ.
    J Pharmacol Exp Ther; 1997 Feb 15; 280(2):584-92. PubMed ID: 9023267
    [Abstract] [Full Text] [Related]

  • 8. Quantitative autoradiographic characterization of the binding of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine ([3H]MK-801) in rat brain: regional effects of polyamines.
    Subramaniam S, McGonigle P.
    J Pharmacol Exp Ther; 1991 Feb 15; 256(2):811-9. PubMed ID: 1671602
    [Abstract] [Full Text] [Related]

  • 9. [3H]ifenprodil binding to NMDA receptors in porcine hippocampal brain membranes.
    Höfner G, Wanner KT.
    Eur J Pharmacol; 2000 Apr 14; 394(2-3):211-9. PubMed ID: 10771286
    [Abstract] [Full Text] [Related]

  • 10. Radioligand binding studies reveal agmatine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodil.
    Gibson DA, Harris BR, Rogers DT, Littleton JM.
    Brain Res; 2002 Oct 11; 952(1):71-7. PubMed ID: 12363406
    [Abstract] [Full Text] [Related]

  • 11. [3H]CGP 39653 binding to the agonist site of the N-methyl-D-aspartate receptor is modulated by Mg2+ and polyamines independently of the arcaine-sensitive polyamine site.
    Reynolds IJ.
    J Neurochem; 1994 Jan 11; 62(1):54-62. PubMed ID: 7903355
    [Abstract] [Full Text] [Related]

  • 12. [3H]dizocilpine association kinetics distinguish stimulatory and inhibitory polyamine sites of N-methyl-D-aspartate receptors.
    Marvizón JC, Baudry M.
    J Neurochem; 1994 Sep 11; 63(3):963-71. PubMed ID: 7914227
    [Abstract] [Full Text] [Related]

  • 13. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
    Carter CJ, Lloyd KG, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1990 May 11; 253(2):475-82. PubMed ID: 1971016
    [Abstract] [Full Text] [Related]

  • 14. Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem.
    Benavides J, Peny B, Ruano D, Vitorica J, Scatton B.
    Brain Res; 1993 Feb 26; 604(1-2):240-50. PubMed ID: 8096157
    [Abstract] [Full Text] [Related]

  • 15. Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines.
    Reynolds IJ, Miller RJ.
    Mol Pharmacol; 1989 Nov 26; 36(5):758-65. PubMed ID: 2555674
    [Abstract] [Full Text] [Related]

  • 16. [3H]MK-801 binding to N-methyl-D-aspartate receptors solubilized from rat brain: effects of glycine site ligands, polyamines, ifenprodil, and desipramine.
    Bakker MH, McKernan RM, Wong EH, Foster AC.
    J Neurochem; 1991 Jul 26; 57(1):39-45. PubMed ID: 1828832
    [Abstract] [Full Text] [Related]

  • 17. 125I-ifenprodil: synthesis and characterization of binding to a polyamine-sensitive site in cerebral cortical membranes.
    Mercer LD, Jarrott B, Beart PM.
    J Neurochem; 1993 Jul 26; 61(1):120-6. PubMed ID: 8515257
    [Abstract] [Full Text] [Related]

  • 18. Human retina contains polyamine sensitive [3H]-ifenprodil binding sites: implications for neuroprotection?
    Sharif NA, Xu SX.
    Br J Ophthalmol; 1999 Feb 26; 83(2):236-40. PubMed ID: 10396205
    [Abstract] [Full Text] [Related]

  • 19. Neomycin is an agonist at a polyamine site on the N-methyl-D-aspartate receptor.
    Pullan LM, Stumpo RJ, Powel RJ, Paschetto KA, Britt M.
    J Neurochem; 1992 Dec 26; 59(6):2087-93. PubMed ID: 1359015
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of [3H]-Ifenprodil binding to polyamine binding sites on rabbit and rat retinal homogenates: role in neuroprotection?
    Sharif NA, Xu SX.
    J Ocul Pharmacol Ther; 1999 Jun 26; 15(3):271-81. PubMed ID: 10385136
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.